CervoMed Inc. Accumulated Other Comprehensive Income
CervoMed Inc. (CRVO) had Accumulated Other Comprehensive Income of $106 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $106.00.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$208.00.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.82K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.82K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $106.00 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$208.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $5.82K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $5.82K 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$783.00 10-Q · filed 2025-08-08 |
| 2025-03-31 | $21.22K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $56.20K 10-K · filed 2026-03-13 |
| 2024-09-30 | $123.16K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$19.70K 10-Q · filed 2024-08-09 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$3.12K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$35.38K 10-Q · filed 2023-08-08 |
| 2022-09-30 | -$86.95K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$86.58K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$49.66K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |